Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
353 studies found for:    "Oligodendroglioma"
Show Display Options
RSS Create an RSS feed from your search for:
"Oligodendroglioma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
Condition: Oligodendrogliomas
Intervention:
2 Recruiting Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
Conditions: Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Palbociclib
3 Completed Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial
Conditions: Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Drug: Temozolomide
4 Completed Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Conditions: Oligoastrocytoma, Mixed;   Anaplastic Oligodendroglioma
Intervention: Drug: Temozolomide
5 Terminated
Has Results
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
Conditions: Astrocytoma;   Glioma;   Oligodendroglioma
Interventions: Drug: Irinotecan Hydrochloride (HCI) Treatment;   Drug: Continued Irinotecan Hydrochloride (HCI) Treatment
6 Completed Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: thiotepa;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
7 Active, not recruiting Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
Conditions: CNS Cancer;   CNS BRAIN
Intervention: Drug: temozolomide followed by high dose busulfan and thiotepa
8 Completed Temozolomide in Treating Patients With Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: temozolomide
9 Unknown  Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
10 Active, not recruiting Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
Conditions: Central Nervous System Tumors;   Brain Tumor
Intervention: Drug: temozolomide
11 Completed Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
12 Active, not recruiting Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
13 Completed Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
14 Recruiting Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma
Condition: Glioma : Oligodendroglioma or Astrocytoma
Intervention: Device: Molecular and cellular tumor print Medical Device (ProTool)
15 Active, not recruiting
Has Results
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Adult Anaplastic Oligodendroglioma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Recurrent Adult Brain Neoplasm
Interventions: Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
16 Not yet recruiting Phase 1 Two Part Dose Escalation Trial of RRx-001 + Radiation + Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
Conditions: Glioblastoma;   Oligodendroglioma;   Anaplastic Oligodendroglioma
Interventions: Drug: RRx-001 dose escalation with TMZ + RT;   Radiation: Radiation;   Drug: Fixed dose Temozolomide (75 mg/m2);   Drug: Fixed RRx-001 weekly;   Drug: Staged TMZ and RRx-001 escalation in maintenance stage;   Drug: TMZ Maintenance
17 Recruiting Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Conditions: Adult Anaplastic Oligodendroglioma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Oligoastrocytoma;   Recurrent Adult Brain Neoplasm
Interventions: Drug: Carboplatin;   Drug: Etoposide Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Mannitol;   Drug: Melphalan;   Other: Quality-of-Life Assessment;   Drug: Sodium Thiosulfate
18 Completed Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Conditions: Anaplastic Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Interventions: Drug: Temozolomide;   Radiation: Focal radiotherapy
19 Terminated Treatment Strategy for Low-grade Gliomas
Conditions: Astrocytomas;   Oligodendrogliomas;   Oligoastrocytoma
Interventions: Radiation: Radiation therapy;   Drug: Temozolomide
20 Completed Neural Basis of Language Processing
Conditions: Oligoastrocytoma;   Astrocytoma;   Oligodendroglioma
Interventions: Device: fMRI;   Procedure: tractography;   Other: neuropsychological examination

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.